| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.0085 |
0.9 |
| mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.0089 |
0.9 |
| mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.9 |
| mRNA |
YM-155 |
GDSC1000 |
pan-cancer |
AAC |
0.0051 |
0.9 |